We are thrilled to highlight a recent seminar that brought together experts to explore how innovation in drug development can move from discovery to first-in-human trials—sometimes in as little as three years.

The event showcased clear strategies and real-world examples of how collaboration and expertise can dramatically speed up the journey from lab to clinic. A standout moment was the impressive work by Ana Slipicevic and the team at One-Carbon Therapeutics AB, whose rapid progress exemplifies what’s possible when science and execution align.

Participants gained valuable insights into the roadmap of drug development, with WuXi AppTec playing a key role in guiding the discussion and reconnecting attendees with the foundational steps of the process.
This gathering was a powerful reminder of how shared knowledge and global collaboration can accelerate breakthroughs—and how Sweden continues to be a vibrant hub for life science innovation.